Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Ilginatinib |
JAK Inhibitor | Hematologic (MPN) | ||
|
Molecule
Ilginatinib
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (MPN)
Drug Class / Mechanism
JAK Inhibitor |
||||
Imatinib |
BCR-ABL Tyrosine Kinase Inhibitor | Hematologic (Leukemia) | ||
|
Molecule
Imatinib
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Leukemia)
Drug Class / Mechanism
BCR-ABL Tyrosine Kinase Inhibitor |
||||
Imetelstat |
Oligonucleotide Telomerase Inhibitor (first-in-class) | Hematologic (MDS) | ||
|
Molecule
Imetelstat
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (MDS)
Drug Class / Mechanism
Oligonucleotide Telomerase Inhibitor (first-in-class) |
||||
Inavolisib |
PI3K Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Inavolisib
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
||||
Infigratinib |
FGFR Inhibitor | Solid Tumour | ||
|
Molecule
Infigratinib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
FGFR Inhibitor |
||||
Inotuzumab Ozogamicin |
ADC | Hematologic | ||
|
Molecule
Inotuzumab Ozogamicin
Therapeutic Category
Targeted Therapy (Antibody-Drug Conjugate)
Oncology Type
Hematologic
Drug Class / Mechanism
ADC |
||||
Interferon Alfa-2a |
Interferon / Interleukin | Both (Solid & Hematologic) | ||
|
Molecule
Interferon Alfa-2a
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
||||
Interferon Alfa-2b |
Interferon / Interleukin | Both (Solid & Hematologic) | ||
|
Molecule
Interferon Alfa-2b
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
||||
Iobenguane I-131 |
Radiotherapeutic / Radiodiagnostic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Iobenguane I-131
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
||||
Iodine-131 Tositumomab |
Radiotherapeutic / Radiodiagnostic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Iodine-131 Tositumomab
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
||||
Ipatasertib |
AKT Inhibitor | Solid Tumour | ||
|
Molecule
Ipatasertib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
AKT Inhibitor |
||||
Iruplinalkib |
ALK / ROS1 / NTRK Inhibitor | Solid Tumour | ||
|
Molecule
Iruplinalkib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
ALK / ROS1 / NTRK Inhibitor |
||||
IlginatinibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (MPN)
Drug Class / Mechanism
JAK Inhibitor |
|
ImatinibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Leukemia)
Drug Class / Mechanism
BCR-ABL Tyrosine Kinase Inhibitor |
|
ImetelstatTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (MDS)
Drug Class / Mechanism
Oligonucleotide Telomerase Inhibitor (first-in-class) |
|
InavolisibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
|
InfigratinibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
FGFR Inhibitor |
|
Inotuzumab OzogamicinTargeted Therapy (Antibody-Drug Conjugate) |
|
|
Therapeutic Category
Targeted Therapy (Antibody-Drug Conjugate)
Oncology Type
Hematologic
Drug Class / Mechanism
ADC |
|
Interferon Alfa-2aImmunotherapy (Cytokine) |
|
|
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
|
Interferon Alfa-2bImmunotherapy (Cytokine) |
|
|
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
|
Iobenguane I-131Radiopharmaceutical / Nuclear Medicine |
|
|
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
|
Iodine-131 TositumomabRadiopharmaceutical / Nuclear Medicine |
|
|
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
|
IpatasertibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
AKT Inhibitor |
|
IruplinalkibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
ALK / ROS1 / NTRK Inhibitor |
|